Clinical Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 280 participants.

Also called NCT02649946

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 280 participants (enrolled count) (from the registry)
Sponsor
  • C. R. Bard Registry lists this organization as the lead sponsor
Registry
  • NCT NCT02649946
Other papers using this trial's data
  • Prospective, randomized, multicenter clinical study comparing a self-expanding covered stent to percutaneous transluminal angioplasty for treatment of upper extremity hemodialysis arteriovenous fistula stenosis Kidney international, 2023-07 DOI, PubMed 36990214

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Australia, Austria, Belgium, Germany, Netherlands, New Zealand, Switzerland (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02649946. Randomized; no masking; primary purpose treatment. Start 2016-06 (actual); primary completion 2018-08 (actual). Results posted on 2019-05-13.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Clinical Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft
Acronym
AVeNEW
Condition
Stenosis
Condition
Restenosis
Intervention (Device)
Covera Vascular Covered Stent following PTA
Intervention (Procedure)
Percutaneous Transluminal Angioplasty (PTA) with Uncoated PTA Balloon
Lead sponsor
C. R. Bard (class: industry)

Record details

Record id
cardio:ct-nct02649946
Content hash
e6c29d9e95b4cc6007a28d1cdab1132bc56e86e3e130733c34ced041ace1b23a